Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis.
Top 10 Research Questions Related to Physical Activity and Multiple Sclerosis.
Excitotoxic mechanisms of ischemic injury in myelinated white matter.
Immunotherapy of Multiple Sclerosis : The State of the Art.
Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway.
Dok2 mediates the CD200Fc attenuation of Abeta-induced changes in glia.
Brainstem PML lesion mimicking MS plaque in a natalizumab-treated MS patient.
Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence?
Overview of the biology of type I interferons.
Anesthetic management of a parturient with neuromyelitis optica.
Alemtuzumab Therapy for Multiple Sclerosis.
Editorial: new avenues of research on multiple sclerosis from the perspective of chronic cerebrospinal venous insufficiency paradigm.
The role of stress-response systems for the pathogenesis and progression of MS.
The relationship between upper leg muscle strength and walking capacity in persons with multiple sclerosis.
Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients.
The Impact of Social Media on Dissemination and Implementation of Clinical Practice Guidelines: A Longitudinal Observational Study.
Effects of early IL-17A neutralization on disease induction in a primate model of experimental autoimmune encephalomyelitis.
Targeting intracerebral inflammation in multiple sclerosis: is it feasible?
Effects of multidisciplinary rehabilitation on chronic fatigue in multiple sclerosis: a randomized controlled trial.
Apolipoprotein E polymorphisms status in Iranian patients with multiple sclerosis.
Low-Voltage-Activated CaV3.1 Calcium Channels Shape T Helper Cell Cytokine Profiles.
PML-IRIS during Fingolimod Diagnosed after Natalizumab Discontinuation.
Animal models of multiple sclerosis: the good, the bad and the bottom line.
The effects of robot-assisted gait training in progressive multiple sclerosis: A randomized controlled trial.
Dose-Escalation Study of T Cell Vaccine in Multiple Sclerosis (DES)
Pages
« first
‹ previous
…
173
174
175
176
177
178
179
180
181
…
next ›
last »